Inhibition by hydroxy-N-methyl elliptinium of precancerous mammary hyperplastic alveolar nodule formation in mice
- 1 February 1984
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 20 (2) , 273-276
- https://doi.org/10.1016/0277-5379(84)90195-0
Abstract
No abstract availableFunding Information
- Ministry of Education, Culture, Sports, Science and Technology (56100480)
This publication has 7 references indexed in Scilit:
- Pharmacokinetics of 2-methyl-9-hydroxyellipticinium acetate (NSC-264137) in cancer patients (phase I study)European Journal of Cancer and Clinical Oncology, 1982
- Phase I clinical study of 9-hydroxy-2N-methyl-ellipticinium acetate (NSC-264137) administered on a 5-day i.v. scheduleEuropean Journal of Cancer and Clinical Oncology, 1982
- Inhibitory effects of potassium thiocyanate on normal and neoplastic mammary development in female micePublished by Elsevier ,1980
- METABOLISM AND DISPOSITION STUDIES OF 9-HYDROXYELLIPTICINE AND 2-METHYL-9-HYDROXYELLIPTICINIUM ACETATE IN ANIMALS1980
- Preliminary trial of 9-hydroxy-2-methyl ellipticinium (NSC 264-137) in advanced human cancersPublished by Elsevier ,1978
- PROLACTIN AND MURINE MAMMARY TUMORIGENESIS - REVIEW1977
- Recent Studies of the Hormonal Influence in Mouse Mammary TumorigenesisPublished by S. Karger AG ,1960